Medizone International, Inc. (OTCMKTS:MZEI) Files An 8-K Other Events

0

Medizone International, Inc. (OTCMKTS:MZEI) Files An 8-K Other Events

Item 8.01 Other Events.

On March 1, 2017, Medizone International, Inc. (the Company)
issued a press release announcing it had entered into an
agreement with EMA Partners, LLC to provide financial advisory
and investment banking services in connection with financing and
commercial development, cooperation, service and distribution
arrangements. Registered broker-dealer services that may be
required by the agreement will be provided by Burch Co., Inc. and
its affiliates.
The Company previously announced on February 27, 2017, that it
would post a document titled Medizone International, Inc.
Investor Update March 2, 2017 (the Investor Update) on the
Companys website and that executives of the Company would hold a
conference call with investors, to be broadcast over the World
Wide Web and by telephone and provide access information, date
and time for the conference call. The Company noted that the call
will consist of brief remarks by the Companys management team,
before moving directly into questions and answers.
A copy of the press release of March 1, 2017, and the Investor
Update, are furnished herewith as Exhibits to this Current Report
on Form 8-K and are incorporated herein by reference. These
documents will be posted on the Companys corporate website,
www.medizoneint.com.
The information in this Current Report is being furnished and
shall not be deemed filed for the purposes of Section 18 of the
Securities Exchange Act of 1934, as amended, or otherwise subject
to the liabilities of that Section. The information in this
Current Report shall not be incorporated by reference into any
registration statement or other document to the Securities Act of
1933, as amended. The furnishing of the information in this
Current Report is not intended to, and does not, constitute a
representation that such furnishing is required by Regulation FD
or that the information this Current Report contains is material
investor information that is not otherwise publicly available.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit Number
Description
99.1
Press Release dated March 1, 2017
99.2
Investor Update March 2, 2017


About Medizone International, Inc. (OTCMKTS:MZEI)

Medizone International, Inc. is engaged in designing, manufacturing and selling a system using ozone in the disinfection of surgical and other medical treatment facilities and in other applications. The Company’s AsepticSure is an ozone-based technology, which is used for the purpose of decontaminating and disinfecting hospital surgical suites, emergency rooms, intensive care units and other enclosed spaces, such as gym locker rooms, laboratories and veterinary clinics. In the AsepticSure system, oxygen atoms are misted into the environment with a hydrogen peroxide vapor and the system’s formula creates Trioxidane. The Company is developing a variant of AsepticSure for governmental use with bio-terrorism countermeasures. AsepticSure has completed safety and preliminary operational trials. During the tests, AsepticSure has demonstrated a turnaround time of approximately 90 minutes for disinfection and reoccupation of the hospital rooms.

Medizone International, Inc. (OTCMKTS:MZEI) Recent Trading Information

Medizone International, Inc. (OTCMKTS:MZEI) closed its last trading session up +0.011 at 0.149 with 39,639 shares trading hands.